Terms: = Pancreatic cancer AND TAL1, TCL5, 6886, ENSG00000162367, SCL, P17542, tal-1
10 results:
1. Genetic Susceptibility in Understanding of pancreatic Ductal Adenocarcinoma Risk: A Decade-Long Effort of the PANDORA Consortium.
Vodickova L; Horak J; Vodicka P
Cancer Epidemiol Biomarkers Prev; 2022 May; 31(5):942-948. PubMed ID: 35506247
[TBL] [Abstract] [Full Text] [Related]
2. Systematic review and meta-analysis of diagnostic performance of CT imaging for assessing resectability of pancreatic ductal adenocarcinoma after neoadjuvant therapy: importance of CT criteria.
Yang HK; Park MS; Choi M; Shin J; Lee SS; Jeong WK; Hwang SH; Choi SH
Abdom Radiol (NY); 2021 Nov; 46(11):5201-5217. PubMed ID: 34331549
[TBL] [Abstract] [Full Text] [Related]
3. Circular RNA Circ-STIL Contributes to Cell Growth and Metastasis in Hepatocellular Carcinoma via Regulating miR-345-5p/AQP3 Axis.
Liu J; He X; Zou Y; Wang K
Dig Dis Sci; 2022 Jun; 67(6):2269-2282. PubMed ID: 34231101
[TBL] [Abstract] [Full Text] [Related]
4. Hsa_circ_0000069 Knockdown Inhibits Tumorigenesis and Exosomes with Downregulated hsa_circ_0000069 Suppress Malignant Transformation via Inhibition of STIL in pancreatic cancer.
Ye Z; Zhu Z; Xie J; Feng Z; Li Y; Xu X; Li W; Chen W
Int J Nanomedicine; 2020; 15():9859-9873. PubMed ID: 33324055
[TBL] [Abstract] [Full Text] [Related]
5. Leukocyte DNA methylation signature differentiates pancreatic cancer patients from healthy controls.
Pedersen KS; Bamlet WR; Oberg AL; de Andrade M; Matsumoto ME; Tang H; Thibodeau SN; Petersen GM; Wang L
PLoS One; 2011 Mar; 6(3):e18223. PubMed ID: 21455317
[TBL] [Abstract] [Full Text] [Related]
6. scl/tal1 interrupting locus derepresses GLI1 from the negative control of suppressor-of-fused in pancreatic cancer cell.
Kasai K; Inaguma S; Yoneyama A; Yoshikawa K; Ikeda H
Cancer Res; 2008 Oct; 68(19):7723-9. PubMed ID: 18829525
[TBL] [Abstract] [Full Text] [Related]
7. Materializing the potential of small interfering RNA via a tumor-targeting nanodelivery system.
Pirollo KF; Rait A; Zhou Q; Hwang SH; Dagata JA; Zon G; Hogrefe RI; Palchik G; Chang EH
Cancer Res; 2007 Apr; 67(7):2938-43. PubMed ID: 17409398
[TBL] [Abstract] [Full Text] [Related]
8. Circadian variation of dihydropyrimidine dehydrogenase mRNA expression in leukocytes and serum cortisol levels in patients with advanced gastrointestinal carcinomas compared to healthy controls.
Raida M; Kliche KO; Schwabe W; Häusler P; Clement JH; Behnke D; Höffken K
J Cancer Res Clin Oncol; 2002 Feb; 128(2):96-102. PubMed ID: 11862480
[TBL] [Abstract] [Full Text] [Related]
9. Pharmacodynamics of topoisomerase I inhibition: Western blot determination of topoisomerase I and cleavable complex in patients with upper gastrointestinal malignancies treated with topotecan.
Liebes L; Potmesil M; Kim T; Pease D; Buckley M; Fry D; Cho J; Adler H; Dar K; Zeleniuch-Jacquotte A; Hochster H
Clin Cancer Res; 1998 Mar; 4(3):545-57. PubMed ID: 9533521
[TBL] [Abstract] [Full Text] [Related]
10. Synthetic hispidin, a PKC inhibitor, is more cytotoxic toward cancer cells than normal cells in vitro.
Gonindard C; Bergonzi C; Denier C; Sergheraert C; Klaebe A; Chavant L; Hollande E
Cell Biol Toxicol; 1997 Mar; 13(3):141-53. PubMed ID: 9088624
[TBL] [Abstract] [Full Text] [Related]
